Supreme Court decision regarding the 5th Requirement of the Doctrine of
|
|
- Gabriel Bruce
- 5 years ago
- Views:
Transcription
1 Asamura NEWS Vol. 26 July 2018 Kenji Wada Attorney at Law Asamura Law Offices Mari Yuge Patent Attorney Chemical Department Hisashi Kanamori Patent Attorney Chemical Department Supreme Court decision regarding the 5th Requirement of the Doctrine of Equivalents ( Special Circumstance ) Is a flexible bar approach introduced into the doctrine of equivalents in Japan? Intellectual Property High Court decision on the support requirement A problem to be solved by the invention should be determined in principle based on the descriptions in the specification Intellectual Property High Court Grand Panel decision on prior-art eligibility A general formula having a huge number of options for substituents does not work as prior art. 1
2 1. Heisei 28 [Ju] 1242 Supreme Court decision: Is a flexible bar approach introduced into the doctrine of equivalents in Japan? Summary of facts The plaintiff was the owner of Japanese Patent No entitled Intermediates for the synthesis of vitamin D and steroid derivatives and processes for preparation thereof, and the patented invention relates to a process for producing chemical compounds including Maxacalcitol, which is an active pharmaceutical ingredient of drugs for Keratoma ( the patented process ). The defendants imported and sold drugs which contained Maxacalcitol ( the accused products ) in Japan. The process of producing Maxacalcitol contained in the Accused Products ( the accused process ) met all the constituent features recited in the claims of the patent except the isomer type of the Vitamin D structure in the starting material and intermediate material. The starting material and intermediate material in the patented process was cis-type while the same of the accused process was trans-type (see below), and the accused process includes an additional step of conversion from trans to cis. Patented Process: Accused Process: The specification of the patent provides no description of the starting material or intermediate materials with the trans-type vitamin D structure. The plaintiff demanded the defendants to cease importing, selling and offering for sale the accused products 2
3 and to discard the stocks of accused products. The plaintiff asserted on the basis of the doctrine of equivalents that the accused process was equivalent to the patented process and thus fell within the technical scope of the patented process. The Tokyo District Court granted the plaintiff's demand, and the Intellectual Property High Court upheld the district court decision. The first trial defendants (the appellants) made a final appeal to the Supreme Court. The appellants asserted that the accused process was not equivalent to the patented process because there is a special circumstance, for example, the fact that the accused process was excluded intentionally from the patented process in the patent prosecution (5 th requirement of doctrine of equivalents is not satisfied). The appellants argued that the patentee (the first trial plaintiff) could easily recognize the accused process at the time of filing the patent application of the patented process and thus a special circumstance should be affirmed. Main Issue Whether or not there is a special circumstance, for example, the fact that the accused process was excluded intentionally from the claim of the patented process in the patent prosecution. Outline of court decision The Supreme Court dismissed the final appeal, and the decision of the Tokyo District Court in favor of the patentee (first trial plaintiff) which was upheld by the Intellectual Property High Court became final. The reason is as follows: It is prohibited to argue infringement based on the doctrine of equivalents in the event that there is a special circumstance, for example, the fact that the accused process was excluded intentionally from the patented process in the patent prosecution. This is because the estoppel principle prohibits the patentee from making assertion contradictory to the acts previously taken by the patentee. Even if a patent applicant could easily recognize the difference between the claimed product/process of the patent and accused products/processes at the time of filing the patent application but did not make a claim covering the different feature of the accused products/processes, such a fact alone does not let the third parties trust that the applicant excluded the accused products/processes from the technical scope of the invention of the patent. Further, under the first-to-file system, it is unfair to force patent applicants to cover any and all of the features which can be recognized at the time of the applications into the claims. Accordingly, even if the applicant could easily recognize the difference between the claimed product/process of the patent application and accused products/processes at the time of the application but did not make a claim covering such constitution, it is not enough to affirm the special circumstance. On the other hand, in addition to the facts above, when it is further found that the applicant objectively and seemingly showed (or represented) that the applicant was aware that the difference could replace the claimed element but 3
4 intentionally did not make a claim covering it, for example, by describing the difference and replaceability in the specification, then a special circumstance is found. In the present case, there is no proof that the appellee (the patentee) objectively and seemingly showed (or represented) that the appellee (the patentee) was aware that the difference in the accused process can replace the claimed element of the patented process. Thus, no special circumstance is found. Comments In 1998, the Supreme Court established the requirements of the doctrine of equivalents infringement (Ball Spline Case, Heisei 6 [O] 1083 Supreme Court decision) as follows: Under the doctrine of equivalents, even if there is a difference between the claim elements and the accused product/process, infringement can be found under the following five requirements. Requirement 1: The difference is not an essential part of the patented invention. Requirement 2: Even if the difference exists, the purpose of the invention can be achieved, and the same function and effect can be obtained. Requirement 3: A person of ordinary skill in the art could easily recognize such replacement at the time of producing accused product/ practicing accused process. Requirement 4: Accused product/process did not belong to public domain at the time of the patent application, and a person of ordinary skill in the art could not easily conceive the accused product/process by the public domain at the time of the patent application. Requirement 5: There is no special circumstance, for example, the fact that the accused product/process was excluded intentionally from the claim of the patent in the patent prosecution. This Maxacalcitol Supreme Court decision is related to Requirement 5 above, and it upholds the Intellectual Property High Court decision based on the almost same reasoning. However, as stated above, this Supreme Court decision uses the wording the applicant objectively and seemingly showed (or represented) that the applicant was aware that the difference can replace the claimed element but intentionally did not include it in the claims, while the Intellectual Property High Court decision used slightly different wording. It seems that the Supreme Court decision implicitly clarifies that appearance is important, not just a subjective awareness of the patentee, by using the wording above. In the present case, there was no description in the specification of the Patented Process regarding the transtype Vitamin D structure in the starting material. Thus, a special circumstance was not to be found. On the other hand, this Supreme Court decision does not teach us regarding the cases other than either the case there is no description in the specification regarding the difference like this case; or the case such as that there is an explicit description in the specification that the difference is replaceable. 4
5 For example, with regard to the case that there is only an ambiguous/generic description regarding the difference in the specification, we need to await further court judgments. This case is different from that in which the accused product/process had been once recited in the claims at the time of application but was excluded after the filing by the amendment. In this regard, the Research law clerks of the Supreme Court, a judge who conducted the research necessary for the proceedings and drafting the decision of this case, expressed his personal opinion as follows: Although exclusion after the filing by claim amendment is out of the scope of this Supreme Court decision, this Supreme Court decision would be compatible with such potential decision that, even if accused product/process is excluded by amendments from the claims, such a fact alone does not constitute a special circumstance. 2. Heisei 29 [Gyo-ke] Intellectual Property High Court decision: A problem to be solved by the invention should be determined in principle based on the descriptions in the specification. Summary of facts The plaintiff is the owner of Japanese Patent No ( the patent ) entitled Food product containing rice-saccharified material and rice oil and/or inositol. The claims of the patent are as follows: Claim 1: Rice milk comprising a rice-saccharified product and rice oil containing 1 to 40 mass% of γ- oryzanol, wherein the rice milk comprises 0.1 to 10 mass% of the rice oil. Claim 2: The rice milk according to claim 1, further comprising inositol. Claim 3: The rice milk according to claim 2, which comprises 0.01 to 0.5 mass% of inositol. Claim 4: A food comprising rice milk according to any one of claims 1 to 3. The Japan Patent Office (JPO) rendered a decision for grant for the patent, and the patent was once registered. However, the opposition was filed against the patent, and the JPO decided to revoke the patent by reasoning that none of Claims 1 to 4 is supported nor meets the support requirement set forth in the Article 36 (6) (i) of the Patent Act. The patentee filed suit requesting cancellation of the decision in the opposition to the Intellectual Property High Court. Main Issue Whether or not the claims of the patent meet the support requirement. 5
6 Outline of court decision The Intellectual Property High Court dismissed the JPO s decision on the opposition for the following reason: Whether or not the claim of the patent meets the support requirement should be determined by comparing the claims with the descriptions in the specification in order to investigate whether a person of ordinary skill in the art can understand that a problem to be addressed by the invention can be solved by the descriptions of the specification, teaching given thereby and/or the general technical knowledge at the time of filing the patent application. The plaintiff asserted that this criterion should be only used with regard to limited cases 1, but this criterion can be used in a general way. The problem to be solved by the invention, which is the premise of the criterion of the support requirement above, should be found in principle on the basis of the descriptions in the specification while referring to the general technical knowledge. In this case, the specification explicitly states that it is an object of the invention to provide foods containing a rice saccharified product which have richness, sweetness, flavor and the like. On the other hand, the decision on opposition by the JPO alleged the problem to be solved of claim 1 of the patent as to provide products which have a significant difference in richness (creaminess), sweetness and flavor from the rice-milk of embodiment 1-1 in the specification. The defendant (JPO) asserts that the problem to be solved should be found as the problem which has not been solved yet, and the problem described in the speciation ( to provide foods containing a rice-saccharified product which have richness, sweetness, flavor and the like ) should correctly be interpreted as to provide products which have significant difference with regard to richness (creaminess), sweetness and flavor from the rice-milk of embodiment 1-1 in the specification. However, the problem to be solved by the invention should be found in principle on the basis of descriptions in the specification unless there is no description regarding the problem to be solved in the specification. The general technical knowledge can be used only supplementarily in order to understand the details of the descriptions in the specification, and cannot be used in order to find the problem to be solved which is different from the problem described in the specification. As such, the way how the decision on opposition by the JPO finds the problem to be solved is inappropriate. Thus, the problem to be solved by the invention is found to be to provide foods containing a rice-saccharified 1 The criterion comes from the Intellectual Property High Court Grand Panel Decision (Case Number: Heisei 17 [Gyo-ke] No ), which addressed a specific parameter patent. The plaintiff therefore asserted that this criterion should be only applied to such a specific case. Please see our corresponding comments. 6
7 product which have richness, sweetness, flavor and the like. The descriptions in the specification sufficiently support and show how to solve this problem. The decision on opposition by the JPO made an unreasonable decision regarding the support requirement, and it is thus illegal. Comments The criterion of the support requirement referred to in the decision above has been established by the Intellectual Property High Court (Grand Panel) decision (Case Number: Heisei 17 [Gyo-ke] No ) ( the Grand Panel decision ). This criterion has been cited in many Intellectual Property High Court decisions rendered since the Grand Panel decision. However, the scope of applicability of this criterion has been still under discussion partly because the patent at issue in the case of the Grand Panel decision was so-called Parameter Patent with special claim form including inequality using parameters such as Y > X and X 65. In fact, there was an Intellectual Property High Court decision which pointed out this particularity of the Grand Panel decision and used different criterion regarding the support requirement. Under these circumstances, this Intellectual Property High Court decision provided a guide in relation to the support requirement issue by confirming that the criterion given in the Grand Panel case can be used in a general way. The Grand Panel decision did not specifically rule how to determine a problem to be solved by the invention. However, as this Intellectual Property High Court decision states, what is a problem to be solved by the invention is the premise of the criterion to assess the support requirement. This Intellectual Property High Court decision has clearly ruled that a problem to be solved by the invention should be determined in principle based on the descriptions in the specification. From the perspective of the support requirement, it is very important to include explicit description regarding the problem in the specification. If not, there is a risk that unintended problem would be decided to be found based on the general technical knowledge (and maybe public domain at the time of application). In addition, it is also important to describe a problem to be addressed by the claimed invention in as general a way as possible, at least from the perspective of the support requirement. 3. Heisei 28 [Gyo-ke] Intellectual Property High Court Grand Panel decision: A general formula having a huge number of options for substituents does not constitute prior art. Summary of facts Nippon Chemipha (generic company) filed suit with the Intellectual Property High Court to cancel a decision to dismiss a demand for invalidation against Japanese Patent No ( the patent ) entitled Pyrimidine Derivative, the patentee being Shionogi & Co., Ltd. Claim 1 of the patent is as follows: Claim 1: A compound represented by the formula (I), 7
8 wherein R¹ is lower alkyl, R 2 is phenyl substituted with halogen, R 3 is lower alkyl, R 4 is hydrogen or calcium ion which forms hemicalcium salt, X is imino having a substituent of alkylsulfonyl, and the dotted line represents the presence or absence of a double bond; or a corresponding ring-closed lactone thereof. This compound covers a product under the tradename Crestor, HMG-CoA reductase inhibitor. The plaintiff asserted that the compound of the patent lacks inventive step over D1 (JPH , primary prior art) in combination with D2 (JPH , secondary prior art). D1 (JPH ) discloses in Example 1 the following compound: (M=Na) D2 (JPH ) describes a compound represented by formula (I). wherein R 1 is... alkyl; R 2,... aryl; and R 3,... -NR 4 R 5, wherein R 4 is... alkyl; R 5,... alkylsulfonyl; X,... -CH=CH-; and A,..., wherein R 6 is hydrogen... ; and R 7,... cation. 8
9 D2 also lists, as a more preferable compound, isopropyl as R 1, phenyl monosubstituted with fluorine, - NR 4 R 5 wherein R 4 is methyl and R 5 is methylsulfonyl as R 3, and calcium cation as R 7. On the other hand, R 3 list includes more than 20 million combinations in the more preferable compounds. Moreover, -NR 4 R 5 as R 3 is not listed in most preferable compounds and there is no Example which exemplifies a compound having the specific combination of -NR 4 R 5 as R 3. Main Issue Whether or not the present invention has an inventive step over D1 and D2. Outline of court decision The Intellectual Property High Court upheld the decision rendered by the JPO in the Invalidation trial. The reason is as follows: 1. Criterion When a prior-art compound is represented by a general formula having a huge number of options for substituents (Markush claim), unless there is a reasonable circumstance to positively or preferentially select a technical idea directed to a specific combination, a technical idea regarding the specific combination cannot be identified and such a prior-art compound is not eligible as an invention in sense of Article 29 of the Patent Act, which is used for novelty and inventive-step assessment. Whether the prior art is primary or secondary, the same idea applies. Re. Relevant case The Intellectual Property High Court first found that the compound of the present patent differs from the compound in D1 in the following aspect. - Difference 1: The former has imino substituted with alkylsulfonyl (i.e. (-N(CH 3 )(SO 2 R ) ) as X, while the latter has imino substituted with methyl (i.e. (-N(CH 3 ) 2 ) ) as X. - Difference 2: The former has H or Ca 2+ as R 4, while the latter has Na + as R 4. Regarding Difference 1, the Intellectual Property High Court found imino substituted with methylsulfonyl to be one of more than 20 million in R3, and ruled that there are no reasonable circumstances to positively or preferentially select (-N(CH 3 )(SO 2 R ) as R 3 and hence D2 is not eligible for the cited invention. The Intellectual Property High Court then concluded that the Difference 1 could not have been easily conceived of by combining the invention of D1 with the invention of D2. Comments If there is an example of a compound having the specific combination of (-N(CH 3 )(SO 2 R ) as R 3, 9
10 Pharmacological data on HMG-CoA reductase inhibitory activity for the compound with (-N(CH 3 )(SO 2 R ) as R 3 are provided, and/or the compound with the specific combination of (-N(CH 3 )(SO 2 R ) as R 3 is listed as one of most preferable compounds in D2, the Intellectual Property High Court would consider that there were reasonable circumstances to positively or preferentially select (-N(CH 3 )(SO 2 R ) as R 3 and thus D2 is eligible for the cited invention. In this view, when it appears that a prior-art compound represented by a general formula may encompass a certain compound which is being considered for a new patent application, it is recommendable to check if there are reasonable circumstances, for example as stated above. If there are no reasonable circumstances, such prior-art compound would not destroy novelty and inventive step of an invention directed to the certain compound which is being considered for the new patent application. From the perspective of challenging a patent, it should be noted that mere listing of options would not have prior-art effects. ********************************************************* Disclaimer The information, material and opinions in this newsletter do not constitute legal or professional advice, and Asamura Patent Office, p.c., is not responsible for any direct or indirect losses resulting from their use. Copyright ASAMURA PATENT OFFICE, p.c. All Rights Reserved. 10
Case Information Pyrimidine Derivative Case
Summary authored by Nobuyuki Akagi Case Information Case Pyrimidine Derivative Case Court, case no. Grand Panel of IP High Court ((H28) 2016 (Gyo-Ke) 10182, 10184)) Date of judgment April 13, 2018 Parties
More informationIntellectual Property High Court
Intellectual Property High Court 1. History of the Divisions of the Intellectual Property High Court ( IP High Court ) The Intellectual Property Division of the Tokyo High Court was first established in
More informationPatent Infringement Litigation Case Study (1)
Patent Infringement Litigation Case Study (1) Mr. Shohei Oguri * Patent Attorney, Partner EIKOH PATENT OFFICE Case 1 : The Case Concerning the Doctrine of Equivalents 1 Fig.1-1: Examination of Infringement
More informationSection I New Matter. (June 2010) 1. Relevant Provision
Section I New Matter 1. Relevant Provision Patent Act Article 17bis(3) reads: any amendment of the description, scope of claims or drawings shall be made within the scope of the matters described in the
More informationPatent Act) I. Outline of the Case The plaintiff filed a request to the Japan Patent Office (JPO) for a trial for invalidation of Patent No e
Case number 2006 (Gyo-Ke) 10563 Parties [Plaintiff] Tamura Kaken Corporation [Defendant] Taiyo Ink MFG. Co., Ltd Decided on May 30, 2008 Division Grand Panel Holdings: - Where a correction does not add
More informationChapter 2 Amendment Adding New Matter (Patent Act Article 17bis(3))
Note: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail. Part IV Chapter 2 Amendment Adding New Matter Chapter 2 Amendment Adding New Matter
More informationJudgments of Intellectual Property High Court ( Grand Panel ) Date of the Judgment: Case Number: 2005(Gyo-Ke)10042
Judgments of Intellectual Property High Court ( Grand Panel ) Date of the Judgment: 2005.11.11 Case Number: 2005(Gyo-Ke)10042 Title(Case): Judgment upholding a Decision of Revocation in an opposition procedure
More informationpatentees. Patent judgment rules in Japanese legal system In this part, to discuss the patent judgment rules in Japan legal system, we will discuss th
11 Comparative Study on Judgment Rules of Patent Infringement in China and Japan (*) Invited Researcher: ZHANG, Xiaojin (**) The Supreme Court of P.R.C issued the Judicial Interpretation on Several Issues
More informationPatent Invalidation Defense v. Correction of Claims Counter-Assertion in Patent Infringement Litigation
Patent Invalidation Defense v. of Claims Counter-Assertion in Patent Infringement Litigation January 27, 2009 TMI Associates Yoshi Inaba Current Situation for Patent Infringement Litigation 2 1 Latest
More informationGuidebook. for Japanese Intellectual Property System 2 nd Edition
Guidebook for Japanese Intellectual Property System 2 nd Edition Preface This Guidebook (English text) is prepared to help attorneys-at-law, patent attorneys, patent agents and any persons, who are involved
More informationInventive Step. Japan Patent Office
Inventive Step Japan Patent Office Outline I. Overview of Inventive Step II. Procedure of Evaluating Inventive Step III. Examination Guidelines in JPO 1 Outline I. Overview of Inventive Step II. Procedure
More informationPatent Infringement Litigation Case Study (2)
Patent Infringement Litigation Case Study (2) - Patent Infringement Under the Doctrine of Equivalents in Japan - Japan Patent Office Asia-Pacific Industrial Property Center, JIII 2006 Collaborator : Shohei
More informationEnforcement of Foreign Patents in Japanese Courts
Enforcement of Foreign Patents in Japanese Courts July 22, 2006 Maki YAMADA Judge, Tokyo District Court 1 About Us: IP Cases in Japan Number of IP cases filed to the courts keeps high. Expediting of IP
More informationCOMPARATIVE STUDY REPORT INVENTIVE STEP (JPO - KIPO - SIPO)
COMPARATIVE STUDY REPORT ON INVENTIVE STEP (JPO - KIPO - SIPO) CONTENTS PAGE COMPARISON OUTLINE COMPARATIVE ANALYSIS I. Determining inventive step 1 1 A. Judicial, legislative or administrative criteria
More informationChemical Patent Practice. Course Syllabus
Chemical Patent Practice Course Syllabus I. INTRODUCTION TO CHEMICAL PATENT PRACTICE: SETTING THE STAGE FOR DISCUSSING STRATEGIES FOR REDUCING RISK OF UNENFORCEABILITY AND ENHANCING CHANCES OF INFRINGEMENT,
More informationPatent Resources Group. Chemical Patent Practice. Course Syllabus
Patent Resources Group Chemical Patent Practice Course Syllabus I. INTRODUCTION II. USER GUIDE: Overview of America Invents Act Changes with Respect to Prior Art III. DRAFTING CHEMICAL CLAIMS AND SPECIFICATION
More informationEUROPEAN PATENT LITIGATORS ASSOCIATION (EPLIT)
Litigators Asscociation EUROPEAN PATENT LITIGATORS ASSOCIATION (EPLIT) ACTAVIS V LILLY MILAN, 14 MAY 2018 EUROPEAN PATENT LITIGATORS ASSOCIATION Actavis UK Limited and others (Appellants) v Eli Lilly and
More informationNovelty. Japan Patent Office
Novelty Japan Patent Office Outline I. Purpose of Novelty II. Procedure of Determining Novelty III. Non-prejudicial Disclosures or Exceptions to Lack of Novelty 1 Outline I. Purpose of Novelty II. Procedure
More informationRecent EPO Decisions: Part 1
Oliver Rutt RSC Law Group IP Case Law Seminar 9 November 2017 Decisions G1/15 Partial Priority T260/14 Partial Priority T1543/12 Sufficiency T2602/12 Admissibility T2502/13 Article 123(2) EPC / Disclaimers
More information2016 Study Question (Patents)
2016 Study Question (Patents) Submission date: 25th April 2016 Sarah MATHESON, Reporter General John OSHA and Anne Marie VERSCHUUR, Deputy Reporters General Yusuke INUI, Ari LAAKKONEN and Ralph NACK, Assistants
More informationRecent Situation of the Japanese Intellectual Property Protection Scheme
Recent Situation of the Japanese Intellectual Property Protection Scheme Japan Patent Attorneys Association 1/51 INDEX / LIST OF DOCUMENTS SECTION 1: Changes in Environments for Obtaining IP rights in
More informationOUTLINE AND EVALUATION OF THE DOUBLE TRACK SYSTEM IN JAPAN--- INVALIDITY DEFENSE IN PATENT INFRINGEMENT LITIGATIONS AND INVALIDITY TRIALS AT JPO
OUTLINE AND EVALUATION OF THE DOUBLE TRACK SYSTEM IN JAPAN--- INVALIDITY DEFENSE IN PATENT INFRINGEMENT LITIGATIONS AND INVALIDITY TRIALS AT JPO November 18,2016 Chief Judge Ryuichi Shitara Intellectual
More informationPartial Priorities and Transfer of Priority Rights. Dr. Joachim Renken
Partial Priorities and Transfer of Priority Rights Dr. Joachim Renken AN EXAMPLE... 15 C Prio 20 C Granted Claim 10 C 25 C In the priority year, a document is published that dicloses 17 C. Is this document
More informationIPPT , TBA-EPO, AgrEvo. Technical Board of Appeal EPO, 12 september 1995, AgrEvo [T 939/92]
Technical Board of Appeal EPO, 12 september 1995, AgrEvo [T 939/92] PATENT LAW No lack of support of claim in case of incredible description A claim concerning a group of chemical compounds is not objectionable
More informationExamination Guidelines for Patentability - Novelty and Inventive Step. Shunsuke YAMAMOTO Examination Standards Office Japan Patent Office 2016.
Examination Guidelines for Patentability - Novelty and Inventive Step Shunsuke YAMAMOTO Examination Standards Office Japan Patent Office 2016.09 1 Outline 1. Flowchart of Determining Novelty and Inventive
More informationINVALIDITY DEFENSE IN PATENT INFRINGEMENT LITIGATIONS IN JAPAN. July 25,2014 Chief Judge Ryuichi Shitara Intellectual Property High Court
INVALIDITY DEFENSE IN PATENT INFRINGEMENT LITIGATIONS IN JAPAN July 25,2014 Chief Judge Ryuichi Shitara Intellectual Property High Court INVALIDATION TRIAL AT JPO Article 123of the Patent Act (2) Any person
More informationChapter 1 Requirements for Description
Note: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail. Part II Chapter 1 Section 1 Enablement Requirement Chapter 1 Requirements for Description
More informationby the plaintiff's product Based on the determination using the method of determining patent infringement under the U.S. patent law, the plaintiff's
Date October 16, 2003 Court Tokyo District Court Case number 2002 (Wa) 1943 [i] A case in which the court found that the plaintiff's product does not fall within the technical scope of the defendant's
More informationOLIVE & OLIVE, P.A. INTELLECTUAL PROPERTY LAW
OLIVE & OLIVE, P.A. INTELLECTUAL PROPERTY LAW Since 1957 500 MEMORIAL ST. POST OFFICE BOX 2049 DURHAM, NORTH CAROLINA 27702-2049 (919) 683-5514 GENERAL RULES PERTAINING TO PATENT INFRINGEMENT Patent infringement
More informationSelection Inventions the Inventive Step Requirement, other Patentability Criteria and Scope of Protection
Question Q209 National Group: Title: Contributors: AIPPI Indonesia Selection Inventions the Inventive Step Requirement, other Patentability Criteria and Scope of Protection Arifia J. Fajra (discussed by
More informationAbstract. Keywords. Kotaro Kageyama. Kageyama International Law & Patent Firm, Tokyo, Japan
Beijing Law Review, 2014, 5, 114-129 Published Online June 2014 in SciRes. http://www.scirp.org/journal/blr http://dx.doi.org/10.4236/blr.2014.52011 Necessity, Criteria (Requirements or Limits) and Acknowledgement
More informationNotwithstanding Article 29, any invention that is liable to injure public order, morality or public health shall not be patented (Article 32).
Japan Patent Office (JPO) Contents Section 1: General... 1 Section 2: Private and/or non-commercial use... 2 Section 3: Experimental use and/or scientific research... 3 Section 4: Preparation of medicines...
More informationClaims and Determining Scope of Protection
Introduction 2014 APAA Patents Committee Questionnaire Claims and Determining Scope of Protection for Taiwan Group Many practitioners and users of the patent system believe that it is a fairly universal
More informationClaim amendments - a case for national proceedings in the life science field?
Claim amendments - a case for national proceedings in the life science field? Dr. Leo Polz German Patent Attorney European Patent Attorney Partner Dott. Marco Benedetto Italian Patent Attorney European
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit 2007-1074 SCHWARZ PHARMA, INC. and SCHWARZ PHARMA AG, Plaintiffs-Appellants, and WARNER-LAMBERT COMPANY, LLC, Plaintiff, v. PADDOCK LABORATORIES,
More informationPatentability what will a Patent Office allow? Darren Smyth 29 January 2010
Patentability what will a Patent Office allow? Darren Smyth 29 January 2010 Requirements for patentability Novelty Inventive step Industrially applicable Not excluded from patentability US Health Warning
More informationPart III Patentability
Note: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail. Part III Patentability Contents Chapter 1 Eligibility for Patent and Industrial Applicability
More informationDecade History and Future Prospects of Intellectual Property High Court Chief Judge of the Intellectual Property High Court Shitara, Ryuichi
Decade History and Future Prospects of Intellectual Property High Court Chief Judge of the Intellectual Property High Court Shitara, Ryuichi I Introduction Since the Intellectual Property High Court (herein
More informationThe Same Invention or Not the Same Invention? Thorsten Bausch
The Same Invention or Not the Same Invention? Thorsten Bausch FICPI World Congress Munich 2010 CONTENTS The Same Invention or Not the Same Invention? Practical Problems The standard of sameness the skilled
More informationDate May 16, 2014 Court Intellectual Property High Court, Case number 2013 (Ne) 10043
Date May 16, 2014 Court Intellectual Property High Court, Case number 2013 (Ne) 10043 Special Division A case in which the court found that the appellee's products fall within the technical scope of the
More informationCurrent Status and Challenges concerning IP Litigation in China
Current Status and Challenges concerning IP Litigation in China 2013 by Dr. Jiang Zhipei KING & WOOD MALLESONS 1 Current Status of IP Litigation in China 2 1.1 Statistics 3 1.1 Statistics The number of
More informationPatent Term Extensions in Taiwan
This article was published in the Markgraf Ergänzende Schutzzertifikate - Patent Term Extensions on 2015. Patent Term Extensions in Taiwan I. Introduction Ruth Fang, Lee and Li Attorneys at Law The patent
More informationGlobal Patent Litigation Strategy and Practice. General Editors Willem A. Hoyng Frank W.E. Eijsvogels
Global Patent Litigation Strategy and Practice General Editors Willem A. Hoyng Frank W.E. Eijsvogels Published by: Kluwer Law International B.V. P.O. Box 316 2400 AH Alphen aan den Rijn The Netherlands
More informationENGLISH SEMINAR OF INTELLECTUAL PROPERTY BY IP GRADUATE SCHOOL UNION. Patent Law. August 2, 2016
ENGLISH SEMINAR OF INTELLECTUAL PROPERTY BY IP GRADUATE SCHOOL UNION Patent Law August 2, 2016 Graduate School of Intellectual Property NIHON University Prof. Hiroshi KATO, Ph.D. katou.hiroshi@nihon-u.ac.jp
More informationReview of Current Status of Post-Grant Opposition System in Comparison with Invalidation Trial System
Seiwa Patent & Law (IP Information Section) Dated April 29, 2016 Review of Current Status of Post-Grant Opposition System in Comparison with Invalidation Trial System Miyako Saito (patent attorney) and
More informationDrafting international applications with Europe in mind. Dr. Matthew Barton, UK and European patent attorney, Forresters
Drafting international applications with Europe in mind Dr. Matthew Barton, UK and European patent attorney, Forresters Introduction The European patent office (EPO) perhaps has a reputation for having
More informationCase number 2011 (Wa) 38969
Date February 28, 2013 Court Tokyo District Court, Case number 2011 (Wa) 38969 46th Civil Division A case in which the court found that an act of exercising the right to demand damages based on a patent
More informationFreedom to Operate and Selected Issues
Freedom to Operate and Selected Issues March 9, 2010 Presented by: Cary A. Levitt My principal business consists of giving commercial value to the brilliant, but misdirected, ideas of others... Accordingly,
More informationTHE SUPREME COURT'S DECISION IN
THE SUPREME COURT'S DECISION IN June 20, 2002 On May 28, the U.S. Supreme Court issued its longawaited decision in Festo Corporation v. Shoketsu Kinzoku Kogyo Kabushiki Co., Ltd., 1 vacating the landmark
More informationWorking Guidelines Q217. The patentability criteria for inventive step / non-obviousness
Working Guidelines by Thierry CALAME, Reporter General Nicola DAGG and Sarah MATHESON, Deputy Reporters General John OSHA, Kazuhiko YOSHIDA and Sara ULFSDOTTER Assistants to the Reporter General Q217 The
More informationEUROPEAN GENERIC MEDICINES ASSOCIATION
EUROPEAN GENERIC MEDICINES ASSOCIATION POSITION PAPER POSITION PAPER ON THE REVIEW OF DIRECTIVE 2004/48/EC ON THE ENFORCEMENT OF INTELLECTUAL PROPERTY RIGHTS JUNE 2011 EGA EUROPEAN GENERIC MEDICINES ASSOCIATION
More informationUnited States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Federal Circuit TEVA PHARMACEUTICAL INDUSTRIES LTD., Plaintiff-Appellant, v. ASTRAZENECA PHARMACEUTICALS LP AND IPR PHARMACEUTICALS INC., Defendants-Appellees. 2011-1091
More informationMerck Sharp & Dohme & Anr. v Glenmark Pharmaceuticals Ltd
BIOTECH BUZZ International Subcommittee December 2015 Contributor: Archana Shanker Changing trends in Indian patent enforcement In the history of the Patent Litigation in India, at least since 1970, only
More informationCOMPARATIVE STUDY REPORT TRILATERAL PROJECT 12.4 INVENTIVE STEP - 1 -
COMPARATIVE STUDY REPORT ON TRILATERAL PROJECT 12.4 INVENTIVE STEP - 1 - CONTENTS PAGE COMPARISON OUTLINE COMPARATIVE ANALYSIS I. Determining inventive step 1 1 A. Judicial, legislative or administrative
More informationThird Party Observations, Oppositions & Invalidation Trials of Patents in Japan
Third Party Observations, Oppositions & Invalidation Trials of Patents in Japan Aki Ryuka Japanese Patent Attorney Attorney at Law, California, U.S.A. October 12, 2015 This information is provided for
More informationDRAFT. prepared by the International Bureau
December 2, 2004 DRAFT ENLARGED CONCEPT OF NOVELTY: INITIAL STUDY CONCERNING NOVELTY AND THE PRIOR ART EFFECT OF CERTAIN APPLICATIONS UNDER DRAFT ARTICLE 8(2) OF THE SPLT prepared by the International
More informationPATENT REEXAMINATION BOARD OF THE STATE INTELLECTUAL PROPERTY OFFICE OF THE PEOPLE S REPUBLIC OF CHINA EXAMINATION DECISION OF INVALIDATION REQUEST
PATENT REEXAMINATION BOARD OF THE STATE INTELLECTUAL PROPERTY OFFICE OF THE PEOPLE S REPUBLIC OF CHINA EXAMINATION DECISION OF INVALIDATION REQUEST Decision No. 9817 Decision Date April 29, 2007 Title
More informationFEDERAL CIRCUIT DECISIONS FOR WEEK ENDING May 25, 2018
P+S FEDERAL CIRCUIT SUMMARIES VOL. 10, ISSUE 18 FEDERAL CIRCUIT DECISIONS FOR WEEK ENDING May 25, 2018 Artrip v. Ball Corp., Case No. 2018-1277 (May 23, 2018) (non-precedential) Patent Nos. 5,660,516,
More information24 Criteria for the Recognition of Inventors and the Procedure to Settle Disputes about the Recognition of Inventors
24 Criteria for the Recognition of Inventors and the Procedure to Settle Disputes about the Recognition of Inventors Research Fellow: Toshitaka Kudo Under the existing Japanese laws, the indication of
More informationPatent Disputes and Related Actions
Patent Disputes and Related Actions Japan Patent Office Asia-Pacific Industrial Property Center, JIII 2011 Collaborator: Izumi Hayashi, ATTONEY-AT-LAW, EITAI SOGO LAW OFFICES Patent Disputes and Related
More informationChief Judge of the IP High Court Makiko Takabe
Chief Judge of the IP High Court Makiko Takabe 1 Today s Topic I. Introduction II. Structure of IP High Court III. Management of Proceedings at IP High Court IV.IP High Court in the Era of Globalization
More informationCOMMENTARY. Antidote to Toxic Divisionals European Patent Office Rules on Partial Priorities. Summary of the Enlarged Board of Appeal s Decision
March 2017 COMMENTARY Antidote to Toxic Divisionals European Patent Office Rules on Partial Priorities Beginning in 2009, the Boards of Appeal of the European Patent Office ( EPO ) issued a series of decisions
More informationSwitzerland. Esther Baumgartner Christoph Berchtold Simon Holzer Kilian Schärli Meyerlustenberger Lachenal. 1. Small molecules
Esther Baumgartner Christoph Berchtold Simon Holzer Kilian Schärli Meyerlustenberger Lachenal 1. Small molecules 1.1 Product and process claims Classic drug development works with small, chemically manufactured
More informationDecision on Patent Law. Patent Act Secs. 104 ter, 123, 128, Code of Civil Procedure Sec. 338 Knife-processing Device
Decision on Patent Law Patent Act Secs. 104 ter, 123, 128, Code of Civil Procedure Sec. 338 Knife-processing Device A patentee whose patent has been regarded as invalid by the courts can only be heard
More informationQuestionnaire 2. HCCH Judgments Project
Questionnaire 2 HCCH Judgments Project Introduction 1) An important current project of the Hague Conference on Private International Law (HCCH) is the development of a convention on the recognition and
More informationWSPLA (Wash. State Patent Law Assoc.) Lunch Seminar
WSPLA (Wash. State Patent Law Assoc.) Lunch Seminar Date: March 15, 2017 12:00-1:30~2:00 Place: Seattle, WA (Washington Athletic Club 1325 6 th Ave. Seattle 98101) 1 Dos and Don ts of US Inbound & Outbound
More informationOBTAINING DEFENSIBLE PATENTS IN THE PST INDUSTRY
OBTAINING DEFENSIBLE PATENTS IN THE PST INDUSTRY Mark P. Levy, Intellectual Property Practice Group Leader, Thompson Hine LLP., Dayton, Ohio I. The name of the game is the claim. As Judge Rich, one of
More informationSecond medical use or indication claims. Mr. Antonio Ray ORTIGUERA Angara Abello Concepcion Regala & Cruz Law Offices Philippines
Question Q238 National Group: Title: Contributors: Reporter within Working Committee: PHILIPPINES Second medical use or indication claims Mr. Alex Ferdinand FIDER Mr. Antonio Ray ORTIGUERA Angara Abello
More informationInventive Step of Invention
Inventive Step of Invention Japan Patent Office Asia-Pacific Industrial Property Center, JIII 2011 Collaborator: Tetsuo TSUKANAKA, Patent Attorney, Deputy President Sugimura International Patent & Trademark
More informationINTRODUCTION yearbook of IP-related court cases in the fields of chemistry and biotechnology
INTRODUCTION On April 1st last year, 2012 yearbook of IP-related court cases in the fields of chemistry and biotechnology, which lists the court cases presented within the year 2012 (posted on the HP of
More information2016 Study Question (Patents)
2016 Study Question (Patents) Submission date: 9th May 2016 Sarah MATHESON, Reporter General John OSHA and Anne Marie VERSCHUUR, Deputy Reporters General Yusuke INUI, Ari LAAKKONEN and Ralph NACK, Assistants
More informationWe Innovate Healthcare 1
Kimberly J. Prior Hoffmann-La Roche Inc. December 5, 2012 We Innovate Healthcare 1 The doctrine of obviousness-type double patenting is intended to prevent the extension of the term of a patent by prohibiting
More informationContents. m) Amendments without support II: Disclaimers n) Corrections o) Additional limitations of pre-grant amendments p) Amendments after grant
Recent experiences with Art. 123(2) EPC The ban on adding subject-matter not disclosed in the application as filed: An oftentimes neglected provision when drafting patent applications Dr. Joachim Renken
More informationProtection of Intellectual Property Rights in China
Loyola Marymount University and Loyola Law School Digital Commons at Loyola Marymount University and Loyola Law School Loyola of Los Angeles International and Comparative Law Review Law Reviews 12-1-1989
More informationAttachment: Opinions on the Draft Amendment of the Implementing Regulations of the Patent Law of the People s Republic of China
March 31, 2009 To: Legislative Affairs Office State Council People s Republic of China Hirohiko Usui President Japan Intellectual Property Association Opinions on the Draft Amendment of the Implementing
More informationComments on KSR Int'l Co. v. Teleflex, Inc.
Banner & Witcoff Intellectual Property Advisory Comments on KSR Int'l Co. v. Teleflex, Inc. By Joseph M. Potenza On April 30, 2007, the U.S. Supreme Court came out with the long-awaited decision clarifying
More informationSuzannah K. Sundby. canady + lortz LLP. David Read. Differences between US and EU Patent Laws that Could Cost You and Your Startup.
Differences between US and EU Patent Laws that Could Cost You and Your Startup Suzannah K. Sundby United States canady + lortz LLP Europe David Read UC Center for Accelerated Innovation October 26, 2015
More informationDoctrine of Equivalents: Recent Developments in Germany
Doctrine of Equivalents: Recent Developments in Germany Young EPLAW Congress Brussels 24 April 2017 Ole Dirks decisively different Introduction Legal framework: Art. 69 para. 1 EPC / Sec. 14 German Patents
More informationCase 1:18-cv UNA Document 1 Filed 03/27/18 Page 1 of 87 PageID #: 4 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:18-cv-00466-UNA Document 1 Filed 03/27/18 Page 1 of 87 PageID #: 4 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE GILEAD SCIENCES, INC. and GILEAD PHARMASSET LLC, Plaintiffs, v.
More informationWORKSHOP 1: IP INFRINGEMENT AND INTERNATIONAL FORUM SHOPPING
43 rd World Intellectual Property Congress Seoul, Korea WORKSHOP 1: IP INFRINGEMENT AND INTERNATIONAL FORUM SHOPPING October 21, 2012 John Kim* Admitted to practice in Maryland, the District of Columbia,
More information7 Problems Surrounding Intellectual Property Rights under Private International Law
7 Problems Surrounding Intellectual Property Rights under Private International Law Despite the prospected increase in intellectual property (IP) disputes beyond national borders, there are no established
More informationTitle: The patentability criterion of inventive step / non-obviousness
Question Q217 National Group: China Title: The patentability criterion of inventive step / non-obviousness Contributors: [Heather Lin, Gavin Jia, Shengguang Zhong, Richard Wang, Jonathan Miao, Wilson Zhang,
More informationPatent protection in Latin America: Main provisions and recommended strategy
Patent protection in Latin America: Main provisions and recommended strategy Speaker: Mr. Rafael Freire Technical & Legal Services Manager Clarke, Modet & Cº Brazil AGENDA Summary - Patent Prosecution
More informationJudgments of Intellectual Property High Court, Second Division Date of the Judgment: Case Number: 2005(Ne)No.10100, 2005(Ne)No.
Judgments of Intellectual Property High Court, Second Division Date of the Judgment: 2006.2.27 Case Number: 2005(Ne)No.10100, 2005(Ne)No.10116 Title (Case): A case wherein the court held as follows: (1)
More information1. The Japan Patent Office (JPO) fee schedule is changed, effective from. 2. The post-grant opposition system is abolished, and the invalidation trial
2003 AMENDMENT TO JAPAN PATENT LAW April 1, 2004; The Japan Patent Law was amended in 2003. The major changes are: 1. The Japan Patent Office (JPO) fee schedule is changed, effective from 2. The post-grant
More informationIntellectual Property and crystalline forms. How to get a European Patent on crystalline forms?
Intellectual Property and crystalline forms How to get a European Patent on crystalline forms? Ambrogio Usuelli Chief-Examiner European Patent Office, Munich, Germany Bologna, 19th January 2012 Sponsor:
More informationHow (Not) to Discourage the Unscrupulous Copyist
How (Not) to Discourage the Unscrupulous Copyist PETER LUDWIG October 2009 ABSTRACT This article explores how the U.S. and Japanese courts implement the doctrine of equivalence when determining patent
More informationDoctrine of Equivalents: Recent Developments in Switzerland
Doctrine of Equivalents: Recent Developments in Switzerland Young EPLAW Congress Brussels 24 April 2017 Peter Ling 2 1 Introduction Federal Patent Court (2012-) Statutory basis of equivalence - "imitation
More informationCASE NO: 657/95. In the matter between: and CHEMICAL, MINING AND INDUSTRIAL
CASE NO: 657/95 In the matter between: JOHN PAUL McKELVEY NEW CONCEPT MINING (PTY) LTD CERAMIC LININGS (PTY) LTD 1st Appellant 2nd Appellant 3rd Appellant and DETON ENGINEERING (PTY) LTD CHEMICAL, MINING
More informationAllowability of disclaimers before the European Patent Office
PATENTS Allowability of disclaimers before the European Patent Office EPO DISCLAIMER PRACTICE The Boards of Appeal have permitted for a long time the introduction into the claims during examination of
More informationNote: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail. Part III Patentability
Note: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail. Part III Patent Act (Requirements for ) Article 29(1) Any person
More informationPatent Resources Group Federal Circuit Law Course Syllabus
I. Novelty and Loss of Right to a Patent II. III. IV. A. Anticipation 1. Court Review of PTO Decisions 2. Claim Construction 3. Anticipation Shown Through Inherency 4. Single Reference Rule Incorporation
More informationCourt Case Review (Trademarks) Budweiser Case
Court Case Review (Trademarks) Budweiser Case Emi Aoshima(Ms.); Patent Attorney of the Trademark & Design Division The Tokyo High Court rendered a judgement on July 30, 2003 in the so-called Budweiser
More informationHow patents work An introduction for law students
How patents work An introduction for law students 1 Learning goals The learning goals of this lecture are to understand: the different types of intellectual property rights available the role of the patent
More informationIsrael Israël Israel. Report Q192. in the name of the Israeli Group by Tal BAND
Israel Israël Israel Report Q192 in the name of the Israeli Group by Tal BAND Acquiescence (tolerance) to infringement of Intellectual Property Rights Questions 1) The Groups are invited to indicate if
More informationSection 102: A Dead Letter For Qualifying Claims
Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Section 102: A Dead Letter For Qualifying Claims Law360,
More informationRemedies: Injunction and Damages. 1. General
VI. Remedies: Injunction and Damages 1. General If infringement is found and validity of the patent is not denied by the court, then the patentee is entitled to the remedies of both injunction and damages
More informationThe Third Amendment to the Patent Law of China. On December 27, 2008, the Standing Committee of the National People's
The Third Amendment to the Patent Law of China On December 27, 2008, the Standing Committee of the National People's Congress adopted the third amendment to the Patent Law of the People's Republic of China,
More informationRegional Court Düsseldorf. Judgement
Certified copy (copy according to Sec. 169 para. 3 of the German Code of Civil Procedure (ZPO)) 4b O 39/18 Pronounced on 1 October 2018 Beihof, Judicial Officer as Registrar of the Court Regional Court
More informationNews and analysis on IP law, regulation and policy from around the world. For the latest updates, visit
WORLD INTELLECTUAL PROPERTY REPORT >>> News and analysis on IP law, regulation and policy from around the world. For the latest updates, visit www.bna.com International Information for International Business
More information